ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.936,02
0,00%
S&P 500
5.421,03
0,00%
US Dollar vs BRL
5,4086
0,11%
Bitcoin
68.034,15
-0,31%
Brent Oil
82,135
-0,20%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. USOTC
  6. Daiichi Sankyo Company Ltd (PK) (DSNKY)

  7. Daiichi Sankyo Company Ltd (PK) (DSNKY) Notícias

DSNKY

Daiichi Sankyo (PK) (DSNKY)

Daiichi Sankyo Company Ltd (PK)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:USOTC:DSNKY
DataHoraFonteTítuloCódigoCompanhia
23/10/202303:49Dow Jones NewsAstraZeneca, Daiichi Sankyo's Enhertu Gets Approval in EU For Lung Cancer TreatmentUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
19/10/202321:30Dow Jones NewsMerck, Daiichi Sankyo Ink Commercialization Deal for Up to $22 BillionUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
22/09/202303:53Dow Jones NewsAstraZeneca Says Trial Results For Breast Cancer Drug Were Highly PositiveUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
15/09/202311:51Dow Jones NewsAstraZeneca's Lung-Cancer Treatment Gets Recommended for Approval in the EUUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
11/09/202303:55Dow Jones NewsAstraZeneca Says Datopotamab Deruxtecan Combined With Imfinzi Shows High Disease Control RatesUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
03/07/202303:50Dow Jones NewsAstraZeneca Says Datopotamab Deruxtecan Phase 3 Trial Shows Positive Results in Lung Cancer PatientsUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
05/06/202309:53Dow Jones NewsAstraZeneca Cancer Drug Enhertu Shows Clinically Meaningful, Durable Response in TrialUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
14/11/202204:52Dow Jones NewsAstraZeneca Says Enhertu Recommended for EU Approval for Gastric CancerUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
12/08/202203:53Dow Jones NewsAstraZeneca, Daiichi's Enhertu Approved by the FDA for Lung Cancer TreatmentUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
09/08/202207:49Dow Jones NewsAstraZeneca Reports Promising Data From Lung Cancer TrialUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
27/06/202203:55Dow Jones NewsAstraZeneca Enhertu Breast Cancer Drug Is Recommended for EU ApprovalUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
05/05/202204:03Dow Jones NewsAstraZeneca's Enhertu Approved in US for Metastatic Breast Cancer TreatmentUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
19/04/202203:55Dow Jones NewsAstraZeneca, Daiichi Sankyo Say FDA Has Accepted Enhertu for Priority ReviewUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
21/02/202206:38Dow Jones NewsAstraZeneca, Daiichi Sankyo Report Positive Trial Results for Enhertu Breast-Cancer Treatment -- UpdateUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
17/01/202204:54Dow Jones NewsAstraZeneca's Enhertu Granted Priority Review by US RegulatorUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
17/09/202114:05Dow Jones NewsAstraZeneca Sees Positive Results for Enhertu TrialUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
30/03/201904:02Dow Jones NewsCancer Drug Deal Carries High Price -- WSJUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
28/07/201609:10Dow Jones NewsChina's Fosun Close to Deal for India's Gland PharmaUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
20/04/201519:00Dow Jones NewsDaiichi Sankyo to Sell Sun Pharma StakeUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
23/03/201518:44The Motley FoolThis Market Could Grow 6250% in 10 YearsUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
02/12/201418:38Dow Jones NewsAbilify Maker Otsuka to Buy Avanir for $3.5 BillionUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
23/01/201423:12Dow Jones NewsFDA Bars Ingredients From Ranbaxy's India PlantUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
17/09/201307:43Dow Jones NewsASIA MARKETS: China Leads Asia Stocks LowerUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
17/09/201303:03Dow Jones NewsASIA MARKETS: Asia Stocks Mostly Lower Ahead Of Fed MeetingUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
02/09/201305:35Dow Jones NewsASIA MARKETS: Hong Kong Stocks Jump To Lead Broad Asia GainsUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
01/09/201322:28Dow Jones NewsASIA MARKETS: Asia Stocks Rise After Official China Factory DataUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
24/04/201307:50Dow Jones NewsNovartis Boosted by Drug LaunchesUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
22/02/201314:20Dow Jones NewsRanbaxy Resumes Generic Lipitor Production for U.S.USOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
02/10/201214:01Dow Jones NewsArQule, Daiichi Sankyo End Lung-Cancer TrialUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
27/08/201209:04Dow Jones NewsLilly/Daiichi Blood Thinner Misses Mark in Head-to-Head Study Vs PlavixUSOTC:DSNKYDaiichi Sankyo Company Ltd (PK)
 Apresentando as notícias mais relevantes sobre:USOTC:DSNKY

Seu Histórico Recente

NASDAQI
NQSXY
SmartX NASDAQ Quality Di...
LVCN
ATMBTC
ATMChain
UNSW3
GRTUSDT
Graph Token
BIT
UC84CT
Unicredit Bank
BIT
UB8PEM
Unicredit Bank
USOTC
SPIN
Spine Injury Solutions (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados